neoxpress, a novel tcr platform to target solid tumors
Published 2 years ago • 60 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
1:28
phase i trial of ntx1088, a novel anti-pvr mab, in solid tumors
-
8:25
dr. michal sheleg on a novel immunotherapy platform for solid tumor treatment
-
1:19
ly3537982: a novel kras g12c inhibitor in solid tumors
-
2:30
potentiating novel engineered cellular therapies for solid tumors | mass general brigham
-
0:37
the future of adapt-001 in patients with solid tumors refractory to checkpoint inhibitors
-
1:58
tac t-cell development in solid tumors
-
2:36
current challenges in targeting solid tumors with car t-cells
-
2:50
car-t cells versus spear t-cells to treat solid tumors
-
1:00:36
qsp and oncology: how qsp modeling can accelerate therapy development for solid tumors
-
3:57
efficacy and safety of ysch-01 by shanghai yuansong in advanced solid tumors in clinical study
-
7:03
car-t car-nk будущее онкологии
-
2:49
identifying novel antigens for tcr t-cell therapy
-
4:39
tmod cellular logic gate as a solution to on-target, off-tumor toxicity in car-t for solid tumors
-
6:04
cellular therapy in solid tumors
-
1:01:35
new frontiers in immuno-oncology for solid tumor treatment
-
2:57
basecamp-1: developing tmod car t-cell therapy for solid tumors
-
4:26
novel delivery of tlr7/8 agonists for treatment of metastatic solid tumors
-
2:30
the challenge of targeting solid tumors with t cells i til therapies i tcr ts
-
4:58
immatics' ima203 tcr-t therapy shows promising results in solid tumors
-
1:13
tactic-2: tac01-her2, a tac t-cell therapy, in her2 tumors
-
32:38
a new class of cell therapies to target solid tumors
-
38:40
webinar: engineering strategies for improving adoptive t cell therapy against cancer